173 related articles for article (PubMed ID: 23169785)
1. Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice.
Weng H; Ji X; Naito Y; Endo K; Ma X; Takahashi R; Shen C; Hirokawa G; Fukushima Y; Iwai N
Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E187-96. PubMed ID: 23169785
[TBL] [Abstract][Full Text] [Related]
2. PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation.
Li X; Baumgart E; Dong GX; Morrell JC; Jimenez-Sanchez G; Valle D; Smith KD; Gould SJ
Mol Cell Biol; 2002 Dec; 22(23):8226-40. PubMed ID: 12417726
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal β-Oxidation of Very-long-chain Fatty Acids.
Yagita Y; Shinohara K; Abe Y; Nakagawa K; Al-Owain M; Alkuraya FS; Fujiki Y
J Biol Chem; 2017 Jan; 292(2):691-705. PubMed ID: 27899449
[TBL] [Abstract][Full Text] [Related]
4. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
Blankestijn M; Bloks VW; Struik D; Huijkman N; Kloosterhuis N; Wolters JC; Wanders RJA; Vaz FM; Islinger M; Kuipers F; van de Sluis B; Groen AK; Verkade HJ; Jonker JW
Sci Rep; 2022 Feb; 12(1):2512. PubMed ID: 35169201
[TBL] [Abstract][Full Text] [Related]
5. The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress.
Hwang I; Uddin MJ; Pak ES; Kang H; Jin EJ; Jo S; Kang D; Lee H; Ha H
Free Radic Biol Med; 2020 Feb; 148():22-32. PubMed ID: 31877356
[TBL] [Abstract][Full Text] [Related]
6. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
[TBL] [Abstract][Full Text] [Related]
8. Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis.
Asimakopoulou A; Fülöp A; Borkham-Kamphorst E; de Leur EV; Gassler N; Berger T; Beine B; Meyer HE; Mak TW; Hopf C; Henkel C; Weiskirchen R
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2093-2110. PubMed ID: 28396286
[TBL] [Abstract][Full Text] [Related]
9. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.
Hall D; Poussin C; Velagapudi VR; Empsen C; Joffraud M; Beckmann JS; Geerts AE; Ravussin Y; Ibberson M; Oresic M; Thorens B
J Biol Chem; 2010 Oct; 285(40):31011-23. PubMed ID: 20610391
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal oxidation of erucic acid suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation in the rat liver.
Chen X; Shang L; Deng S; Li P; Chen K; Gao T; Zhang X; Chen Z; Zeng J
J Biol Chem; 2020 Jul; 295(30):10168-10179. PubMed ID: 32493774
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver.
Knebel B; Hartwig S; Haas J; Lehr S; Goeddeke S; Susanto F; Bohne L; Jacob S; Koellmer C; Nitzgen U; Müller-Wieland D; Kotzka J
Biochim Biophys Acta; 2015 Jul; 1851(7):965-76. PubMed ID: 25790917
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene.
Fan CY; Pan J; Chu R; Lee D; Kluckman KD; Usuda N; Singh I; Yeldandi AV; Rao MS; Maeda N; Reddy JK
J Biol Chem; 1996 Oct; 271(40):24698-710. PubMed ID: 8798738
[TBL] [Abstract][Full Text] [Related]
15. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet.
Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N
Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377
[TBL] [Abstract][Full Text] [Related]
16. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism.
Hunt MC; Solaas K; Kase BF; Alexson SE
J Biol Chem; 2002 Jan; 277(2):1128-38. PubMed ID: 11673457
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA Derived from Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation.
He A; Chen X; Tan M; Chen Y; Lu D; Zhang X; Dean JM; Razani B; Lodhi IJ
Mol Cell; 2020 Jul; 79(1):30-42.e4. PubMed ID: 32473093
[TBL] [Abstract][Full Text] [Related]
19. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
Tucci S; Behringer S; Spiekerkoetter U
FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop.
Colasante C; Chen J; Ahlemeyer B; Baumgart-Vogt E
Thromb Haemost; 2015 Mar; 113(3):452-63. PubMed ID: 25608554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
